XILINX, INC. | |||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
(In thousands) | |||
| March 30, 2019 |
| March 31, 2018* |
| (unaudited) |
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash, cash equivalents and short-term investments | $ 3,175,684 |
| $ 3,447,570 |
Accounts receivable, net | 335,165 |
| 382,246 |
Inventories | 315,358 |
| 236,077 |
Other current assets | 65,771 |
| 88,695 |
Total current assets | 3,891,978 |
| 4,154,588 |
Net property, plant and equipment | 328,929 |
| 304,117 |
Long-term investments | 53,433 |
| 97,896 |
Other assets | 877,008 |
| 503,946 |
Total assets | $ 5,151,348 |
| $ 5,060,547 |
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable and accrued liabilities | $ 475,036 |
| $ 412,759 |
Current portion of long-term debt | — |
| 499,186 |
Total current liabilities | 475,036 |
| 911,945 |
Long-term debt | 1,234,807 |
| 1,214,440 |
Other long-term liabilities | 579,996 |
| 573,809 |
Stockholders' equity | 2,861,509 |
| 2,360,353 |
Total Liabilities and Stockholders' Equity | $ 5,151,348 |
| $ 5,060,547 |
| |||||||
* Fiscal 2018 balances have been restated to conform to the new revenue recognition standard (ASC 606). |
XILINX, INC. | |||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | |||||||||
(Unaudited) | |||||||||
(In thousands) | |||||||||
| Three Months Ended |
| Twelve Months Ended | ||||||
| March 30, 2019 |
| December 29, 2018 |
| March 31, 2018 |
| March 30, 2019 |
| March 31, 2018 |
SELECTED CASH FLOW INFORMATION: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization of software | $ 21,607 |
| $ 17,974 |
| $ 15,756 |
| $ 70,704 |
| $ 50,172 |
Amortization | 10,195 |
| 7,984 |
| 33,963 |
| 33,656 |
| 46,582 |
Stock-based compensation | 38,748 |
| 38,641 |
| 48,606 |
| 147,942 |
| 153,815 |
Net cash provided by operating activities | 288,007 |
| 313,917 |
| 242,293 |
| 1,091,215 |
| 820,027 |
Purchases of property, plant ,equipment and software | 28,242 |
| 20,270 |
| 20,978 |
| 89,045 |
| 49,918 |
Payment of dividends to stockholders | 91,384 |
| 91,108 |
| 89,302 |
| 364,244 |
| 353,053 |
Repayment of debt | 500,000 |
| — |
| — |
| 500,000 |
| 457,918 |
Repurchases of common stock | — |
| 1,015 |
| 163,448 |
| 161,551 |
| 474,254 |
|
|
|
|
|
|
|
|
|
|
STOCK-BASED COMPENSATION INCLUDED IN: |
|
|
|
|
|
|
|
|
|
Cost of revenues | $ 2,170 |
| $ 2,366 |
| $ 2,006 |
| $ 8,820 |
| $ 8,492 |
Research and development | 23,099 |
| 22,352 |
| 19,011 |
| 86,428 |
| 76,790 |
Selling, general and administrative | 13,479 |
| 13,923 |
| 10,968 |
| 52,694 |
| 51,912 |
Executive transition costs | — |
| — |
| 16,621 |
| — |
| 16,621 |